Article info

Download PDFPDF

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Authors

  1. a rgcarbonero{at}gmail.com
  2. b ramonsalazar{at}iconcologia.net
  3. c ignacioduranmartinez{at}gmail.com
  4. d nachosman79{at}hotmail.com
  5. e lpazaresr{at}seom.org
  6. f jmbozada{at}gmail.com
  7. g Valentina.Boni{at}start.stoh.com
  8. h cwilkinsonblanc{at}phi-medics.co.uk
  9. i len.seymour{at}oncology.ox.ac.uk
  10. j John.Beadle{at}psioxus.com
  11. k Simon.Alvis{at}psioxus.com
  12. l +44-1235-835328 Brian.Champion{at}psioxus.com
  13. m Emiliano.Calvo{at}start.stoh.com
  14. n Kerry.Fisher{at}psioxus.com
View Full Text

Citation

Garcia-Carbonero R, Salazar R, Duran I, et al
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Publication history

  • Received April 20, 2017
  • Accepted August 14, 2017
  • First published September 19, 2017.
Online issue publication 
September 19, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.